目的探究黄芪益肾颗粒联合腹膜透析对慢性肾衰竭(CRF)患者肾功能及血清微RNA-30a(miR-30a)、同型半胱氨酸(Hcy)、胱抑素C(Cys C)表达的影响。方法选取2017年10月—2019年12月医院112例CRF患者进行前瞻性随机对照研究,以计算机生成的随...目的探究黄芪益肾颗粒联合腹膜透析对慢性肾衰竭(CRF)患者肾功能及血清微RNA-30a(miR-30a)、同型半胱氨酸(Hcy)、胱抑素C(Cys C)表达的影响。方法选取2017年10月—2019年12月医院112例CRF患者进行前瞻性随机对照研究,以计算机生成的随机数字表将患者分为研究组(56例)、对照组(56例)。常规治疗基础上,对照组予以腹膜透析,研究组予以黄芪益肾颗粒联合腹膜透析,均连续治疗2个月。比较两组疗效、治疗前、治疗2个月后肾功能指标[血肌酐(Scr)、尿素氮(BUN)、24 h尿蛋白定量(24 h Upro)]、症状积分、血清炎症因子指标[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、C反应蛋白(CRP)]、T淋巴细胞亚群指标(CD_(4)^(+)、CD_(8)^(+)、CD_(4)^(+)/CD_(8)^(+))、miR-30a、Hcy、CysC水平。结果研究组治疗2个月后总有效率(92.86%,52/56)高于对照组(76.79%,43/56)(P<0.05);研究组治疗2个月后血清Scr、BUN及24 h Upro水平均低于对照组(P<0.05);研究组治疗2个月后倦怠乏力、腰膝酸软、夜尿、多尿、水肿、贫血积分均低于对照组(P<0.05);研究组治疗2个月后血清TNF-α、IL-6、CRP水平均低于对照组(P<0.05);研究组治疗2个月后血清CD_(4)^(+)、CD_(4)^(+)/CD_(8)^(+)水平高于对照组,CD_(8)^(+)水平低于对照组(P<0.05);研究组治疗2个月后血清miR-30a、Hcy、CysC水平均低于对照组(P<0.05)。结论CRF患者腹膜透析治疗中联合应用黄芪益肾颗粒,能进一步下调血清miR-30a、Hcy、CysC表达,增强机体免疫功能,促进患者肾功能改善,减轻炎症反应及临床症状,显著提高疗效。展开更多
Background Acute kidney injury(AKI)is a primary feature of renal complications in patients with sepsis.MicroRNA(miRNA/miR)-30a is an essential regulator of cardiovascular diseases,tumors,phagocytosis,and other physica...Background Acute kidney injury(AKI)is a primary feature of renal complications in patients with sepsis.MicroRNA(miRNA/miR)-30a is an essential regulator of cardiovascular diseases,tumors,phagocytosis,and other physical processes,but whether it participates in sepsis-induced AKI(sepsis-AKI)is unknown.We aimed to elucidate the functions and molecular mechanism underlying miR-30a activity in sepsis-AKI.Methods The classical cecal ligation and puncture(CLP)method and lipopolysaccharide(LPS)-induced Human Kidney 2(HK-2)cells were used to establish in vivo and in vitro sepsis-AKI models.Specific pathogen-free and mature male Sprague-Dawley(SD)rats,aged 6–8 weeks(weight 200–250 g),were randomly divided into five-time phase subgroups.Fluid resuscitation with 30 mL/kg 37°C saline was administered after the operation,without antibiotics.Formalin-fixed,paraffin-embedded kidney sections were stained with hematoxylin and eosin.SD rat kidney tissue samples were collected for analysis by real-time quantitative polymerase chain reaction and enzyme-linked immunosorbent assay.HK-2 cells were transfected with hsa-miR-30a-3p mimics or inhibitors,and compared with untreated normal controls.RNA,protein,and cell viability were evaluated by quantitative reverse transcription-polymerase chain reaction(qRT-PCR),western blot,and cell counting kit-8 methods.A Dual-Luciferase Assay Kit(Promega)was used to measure luciferase activity 48 h after transfection with miR-30a-3p mimics.Results Expression levels of miR-30a-3p and miR-30a-5p in renal tissues of the sepsis group were significantly reduced at 12 h and 24 h(P<0.05).Tumor necrosis factor-α(TNF-α)and interleukin-1β(IL-1β)were significantly increased in renal tissue 3 h after the operation in rats(P<0.05),and gradually decreased 6 h,12 h,and 24 h after CLP.Levels of miR-30a-5p and miR-30a-3p were significantly down-regulated at 3 h after LPS treatment(P<0.05),and gradually decreased in HK-2 cells.One hour after LPS(10µg/mL)treatment,TNF-αand IL-1βlevels in HK-2 cells were signi展开更多
文摘目的探究黄芪益肾颗粒联合腹膜透析对慢性肾衰竭(CRF)患者肾功能及血清微RNA-30a(miR-30a)、同型半胱氨酸(Hcy)、胱抑素C(Cys C)表达的影响。方法选取2017年10月—2019年12月医院112例CRF患者进行前瞻性随机对照研究,以计算机生成的随机数字表将患者分为研究组(56例)、对照组(56例)。常规治疗基础上,对照组予以腹膜透析,研究组予以黄芪益肾颗粒联合腹膜透析,均连续治疗2个月。比较两组疗效、治疗前、治疗2个月后肾功能指标[血肌酐(Scr)、尿素氮(BUN)、24 h尿蛋白定量(24 h Upro)]、症状积分、血清炎症因子指标[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、C反应蛋白(CRP)]、T淋巴细胞亚群指标(CD_(4)^(+)、CD_(8)^(+)、CD_(4)^(+)/CD_(8)^(+))、miR-30a、Hcy、CysC水平。结果研究组治疗2个月后总有效率(92.86%,52/56)高于对照组(76.79%,43/56)(P<0.05);研究组治疗2个月后血清Scr、BUN及24 h Upro水平均低于对照组(P<0.05);研究组治疗2个月后倦怠乏力、腰膝酸软、夜尿、多尿、水肿、贫血积分均低于对照组(P<0.05);研究组治疗2个月后血清TNF-α、IL-6、CRP水平均低于对照组(P<0.05);研究组治疗2个月后血清CD_(4)^(+)、CD_(4)^(+)/CD_(8)^(+)水平高于对照组,CD_(8)^(+)水平低于对照组(P<0.05);研究组治疗2个月后血清miR-30a、Hcy、CysC水平均低于对照组(P<0.05)。结论CRF患者腹膜透析治疗中联合应用黄芪益肾颗粒,能进一步下调血清miR-30a、Hcy、CysC表达,增强机体免疫功能,促进患者肾功能改善,减轻炎症反应及临床症状,显著提高疗效。
文摘Background Acute kidney injury(AKI)is a primary feature of renal complications in patients with sepsis.MicroRNA(miRNA/miR)-30a is an essential regulator of cardiovascular diseases,tumors,phagocytosis,and other physical processes,but whether it participates in sepsis-induced AKI(sepsis-AKI)is unknown.We aimed to elucidate the functions and molecular mechanism underlying miR-30a activity in sepsis-AKI.Methods The classical cecal ligation and puncture(CLP)method and lipopolysaccharide(LPS)-induced Human Kidney 2(HK-2)cells were used to establish in vivo and in vitro sepsis-AKI models.Specific pathogen-free and mature male Sprague-Dawley(SD)rats,aged 6–8 weeks(weight 200–250 g),were randomly divided into five-time phase subgroups.Fluid resuscitation with 30 mL/kg 37°C saline was administered after the operation,without antibiotics.Formalin-fixed,paraffin-embedded kidney sections were stained with hematoxylin and eosin.SD rat kidney tissue samples were collected for analysis by real-time quantitative polymerase chain reaction and enzyme-linked immunosorbent assay.HK-2 cells were transfected with hsa-miR-30a-3p mimics or inhibitors,and compared with untreated normal controls.RNA,protein,and cell viability were evaluated by quantitative reverse transcription-polymerase chain reaction(qRT-PCR),western blot,and cell counting kit-8 methods.A Dual-Luciferase Assay Kit(Promega)was used to measure luciferase activity 48 h after transfection with miR-30a-3p mimics.Results Expression levels of miR-30a-3p and miR-30a-5p in renal tissues of the sepsis group were significantly reduced at 12 h and 24 h(P<0.05).Tumor necrosis factor-α(TNF-α)and interleukin-1β(IL-1β)were significantly increased in renal tissue 3 h after the operation in rats(P<0.05),and gradually decreased 6 h,12 h,and 24 h after CLP.Levels of miR-30a-5p and miR-30a-3p were significantly down-regulated at 3 h after LPS treatment(P<0.05),and gradually decreased in HK-2 cells.One hour after LPS(10µg/mL)treatment,TNF-αand IL-1βlevels in HK-2 cells were signi
